[1]
L. D. RIZKITA, YSRAFIL, R. MARTIEN, and I. ASTUTI, “CHITOSAN NANOPARTICLES MEDIATED DELIVERY OF MIR-106B-5P TO BREAST CANCER CELL LINES MCF-7 AND T47D”, Int J App Pharm, vol. 13, no. 1, pp. 129–134, Jan. 2021.